Asgard Therapeutics boosts Board with Drug Dev, Cancer Experts
03 Jun 2025 //
PR NEWSWIRE
Asgard Therapeutics names Shane Olwill Chief Development Officer
26 Mar 2025 //
PR NEWSWIRE
Asgard Therapeutics selects Exothera to bring their viral vector-based immunotherapy
11 Jun 2024 //
PRESS RELEASE
Swedish biotech raises €30M Series A to develop off-the-shelf gene therapy
14 Mar 2024 //
ENDPTS
Novo Holdings Co-Leads EUR 6M Seed Financing in Asgard Therapeutics
09 Nov 2021 //
PRNEWSWIRE